JG
Jain Global Portfolio holdings
AUM
$6.43B
This Quarter Return
-2.08%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.89B
AUM Growth
+$1.55B
(+47%)
Cap. Flow
+$1.57B
Cap. Flow
% of AUM
32.16%
Top 10 Holdings %
Top 10 Hldgs %
38.27%
Holding
1,383
New
643
Increased
198
Reduced
147
Closed
368
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$627M |
| 2 |
NVIDIA
NVDA
|
+$190M |
| 3 |
Microsoft
MSFT
|
+$55.5M |
| 4 |
PPG Industries
PPG
|
+$47.7M |
| 5 |
Tesla
TSLA
|
+$37.8M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$81M |
| 2 |
RTX Corp
RTX
|
+$57.5M |
| 3 |
Broadcom
AVGO
|
+$53.6M |
| 4 |
FedEx
FDX
|
+$52.9M |
| 5 |
ConocoPhillips
COP
|
+$51.7M |
Sector Composition
| 1 | Technology | 19.55% |
| 2 | Industrials | 10.5% |
| 3 | Consumer Discretionary | 8.61% |
| 4 | Healthcare | 6.48% |
| 5 | Materials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Seer Inc
SEER
$117M
| $30.6K | ﹤0.01% |
+18,105
| New | +$30.6K |
|
977
Nordic American Tanker
NAT
$675M
| $30.3K | ﹤0.01% |
+12,300
| New | +$30.3K |
|
978
SELLAS Life Sciences
SLS
$199M
| $29.6K | ﹤0.01% |
+27,400
| New | +$29.6K |
|
|
DHC
979
Diversified Healthcare Trust
DHC
$1.05B
| $29K | ﹤0.01% |
+12,100
| New | +$29K |
|
|
EQC
980
DELISTED
Equity Commonwealth
EQC
| $26.2K | ﹤0.01% |
16,244
-200,129
| -92% | -$322K |
|
981
Lantronix
LTRX
$184M
| $25.5K | ﹤0.01% |
+10,221
| New | +$25.5K |
|
982
Montauk Renewables
MNTK
$290M
| $23.6K | ﹤0.01% |
+11,300
| New | +$23.6K |
|
983
Geron
GERN
$842M
| $22.3K | ﹤0.01% |
14,050
-32,900
| -70% | -$52.3K |
|
984
Alto Ingredients
ALTO
$89M
| $21.9K | ﹤0.01% |
+19,191
| New | +$21.9K |
|
|
MODV
985
DELISTED
ModivCare
MODV
| $18.6K | ﹤0.01% |
+14,173
| New | +$18.6K |
|
986
The Oncology Institute
TOI
$293M
| $18.1K | ﹤0.01% |
+15,900
| New | +$18.1K |
|
987
Vor Biopharma
VOR
$229M
| $17.3K | ﹤0.01% |
+24,054
| New | +$17.3K |
|
988
Origin Materials
ORGN
$81.4M
| $15.9K | ﹤0.01% |
+23,933
| New | +$15.9K |
|
989
MediciNova
MNOV
$62.3M
| $15K | ﹤0.01% |
+10,264
| New | +$15K |
|
990
Biodesix
BDSX
$60.6M
| $9.13K | ﹤0.01% |
+14,598
| New | +$9.13K |
|
991
Ameriprise Financial
AMP
$46.4B
| – | – |
-1,533
| Closed | -$816K |
|
992
AnaptysBio
ANAB
$637M
| – | – |
-12,134
| Closed | -$161K |
|
993
Applied Therapeutics
APLT
$64M
| – | – |
-254,019
| Closed | -$217K |
|
994
Applovin
APP
$193B
| – | – |
-39,171
| Closed | -$12.7M |
|
995
Ares Management
ARES
$39.3B
| – | – |
-3,881
| Closed | -$687K |
|
996
ARK Innovation ETF
ARKK
$7.38B
| – | – |
0
| – | – |
|
997
Arm
ARM
$164B
| – | – |
-7,729
| Closed | -$953K |
|
998
Arcutis Biotherapeutics
ARQT
$2.11B
| – | – |
-32,601
| Closed | -$454K |
|
999
Arrowhead Research
ARWR
$3.99B
| – | – |
-31,064
| Closed | -$584K |
|
1000
Associated Banc-Corp
ASB
$4.36B
| – | – |
-9,500
| Closed | -$227K |
|